Print

Print


San Francisco Chronicle
Tinkering With Tomorrow
China races to lead the world in genetic research, while most of its
citizens are detached from technology
Shai Oster, Chronicle Foreign Service Tuesday, April 3, 2001

Beijing -- This story is one in a series on Pacific Rim issues and culture
that appears every Tuesday in The Chronicle World section.

Despite some lingering safety concerns, the world's most populous
country is set on becoming a global leader in genetic engineering,
seeking to improve medical care and guarantee an adequate food
supply for its 1.2 billion inhabitants.

At a recent science fair touting China's advances in genetic
engineering, huge crowds gathered around a rat and rabbit with
human ears jutting from their bodies. Other displays included tanks
filled with fast-growing fish, pest-resistant wheat, weevil-resistant
cotton and eight perfectly round, red tomatoes.

The exhibit gave Chinese a view of some of the projects under way
at the Ministry of Science. They include transplanting silkworm
genes into goats, producing human organs through a stem cell bank,
cloning corneas as a treatment for glaucoma, and studying gene
pools of some of the nation's 56 ethnic minorities.

Ironically, the research is happening in a nation where three-fourths
of the population still lives in the countryside, working the land with
crude tools and earning an average annual income of $200.

Nevertheless, China was the only developing nation to participate
in the Human Genome Project, a decade-old undertaking to map out
chromosomes that make up the genetic code. Project researchers
hope that by deciphering our genomes, they will be able to develop
cures for hereditary diseases and birth defects.

"Genetic research is like unlocking the secrets of the atom,"
said Si Baoqing, a 31-year-old manager of a state-owned factory
who attended the science exhibit.

"You have to make sure you use it for the betterment of mankind,
not for its detriment."

China's push into genetic engineering began in 1984 with the
opening of a special government agency called the National Center
for Biotechnology Development. Center officials say their current
annual budget is about $60 million.

The country also has the state-funded Human Tissues Research
and Development Center in Shanghai, which calls itself the world's
largest institute engaging in stem cell research to generate organs
such as the heart, liver and lungs -- techniques that are
controversial in the United States.

Chinese scientists believe stem cells can be used to grow body
organs for transplant operations. The U.S. government no longer
funds such research because some kinds of stem cells are culled
from aborted fetuses.

"We need to push forward on tissue engineering," said Chen
Zhang Liang, vice president of the prestigious Beijing University
and a leading genetic researcher.

The Chinese government is also bullish on genetic food products,
though the public's attitude is difficult to gauge.

Unlike the United States or other Western countries, China has no
consumer rights movement or independent watchdog groups.
The state-controlled press has given the issue of genetically modified
food only positive coverage. The knowledge of possible side effects
of such foods is almost nil among the average consumer.

Critics in the West charge that not enough research has been done
on the possible long-term effects of genetically modified crops on the
environment and on people who ingest them. To date, the U.S. Food
and Drug Administration has not found any harmful effects, but
European researchers have said that adverse reactions have occurred
in laboratory tests.

And because China has yet to pass laws to require labeling of all
transgenic foods, few Chinese are aware they are consuming such
products -- primarily Round-Up Ready soybeans produced by the
U.S. biotechnology giant Monsanto that are used in goods ranging
from oil to animal feed.

To be sure, Beijing has also shown concern. While the state
has approved for consumption such genetically altered crops
as sweet peppers, wheat and tomatoes, it has yet to issue licenses
for their commercial distribution.

Chen blamed the delay on China's bureaucratic approval process
and concerns that genetically modified foods will be difficult to export.

Although the government wants such foods to be used for domestic
consumption, it also has a history of allowing the export market to
determine policy.

Chinese tobacco was the world's first commercially produced,
genetically modified organism. But production was halted in the
mid-1990s after consumer fears in several foreign countries prompted
their governments to refuse to buy the tobacco.

The government has also led the call for a tougher United Nations
protocol on import quarantines for genetically altered foods.

"The Chinese government is not as overwhelmingly in support
of GMO (genetically modified organism) as the biotech industry
would like to project in the Western media," said Lo Sze-ping,
a Hong Kong spokesman for Greenpeace.

In fact, Monsanto had envisioned a huge market in China for its
 products because of state support and little public suspicion of
genetically modified crops. The reality has been different.

In Hubei province, for example, about 60 percent of all cotton
crops are from Monsanto weevil-resistant seeds. But China's
weaker intellectual property laws allow farmers to save seeds
for future use. In the United States, such hoarding is considered
illegal because of patent law.

The government is also keen on fostering domestic industry,
and backlash is growing against foreign genetic researchers
operating in the country.

At the recent annual meeting of China's parliament, some members
called for laws restricting such research to "safeguard (China's)
gene varieties," according to the official newspaper, China Daily.

"China should not be a testing ground for foreign GM products,"
said Professor Xia Youfu of the University of International Business
and Economics.

State officials acknowledge the moral questions involved in
genetic engineering.

"Genetic research is a double-edged sword that could have
negative effects," said Han Deguang, a professor with Shanghai's
Chinese National Human Genome Center.

©2001 San Francisco Chronicle

http://www.sfgate.com/cgi-bin/article.cgi?file=/chronicle/archive/2001/04/03/MN174810.DTL&type=tech_article

*********

----------------------------------------------------------------------
To sign-off Parkinsn send a message to: mailto:[log in to unmask]
In the body of the message put: signoff parkinsn